Hong Kong-listed Guangzhou Baiyunshan Pharmaceutical Holdings Co. has agreed to raise as much as RMB10 billion (US$1.6 billion) by selling newly issued A shares to five investors including Shanghai Yunfeng Xinchuang Investment Management Co., Ltd., an investment firm 40% owned by Alibaba Group Holding's chairman, Jack Ma, according to a securities filing. Guangzhou-based Baiyunshan will […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.